NET PROFIT (x1000 EUR)
EMPLOYEES
Eurofins Biopharma Product Testing Denmark A/S
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
1,994
|
1,681
|
1,247 |
| Total assets |
6,631
|
6,033
|
3,988 |
| Current assets |
5,387
|
5,035
|
3,047 |
| Current liabilities |
2,889
|
3,032
|
2,564 |
| Equity capital |
2,494
|
1,747
|
1,370 |
| - share capital |
94
|
94
|
94 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
37.6%
|
29.0%
|
34.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
186.5%
|
166.1%
|
118.8% |
| Return on equity (ROE) |
80.0%
|
96.2%
|
91.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.